Diagnostic News and Research

RSS

IMRISNV and IMRIScardio to be installed in BWH's AMIGO suite

IMRIS Inc. ("IMRIS" or the "Company") and Brigham and Women's Hospital, ("BWH") today announced a comprehensive agreement in support of BWH's vision of bringing the most advanced multi-modality image guided therapy suite in the world to its facility in Boston, Massachusetts.

3 Oct 2009

Texas Health Presbyterian Hospital opens Hamon Tower for treating critically ill patients

Texas Health Presbyterian Hospital Dallas announces the opening of the Hamon Tower, the largest expansion in the hospital's history -- a medical complex devoted to intensive care for the region's most critically ill patients.

3 Oct 2009

Advanced Liquid Logic awarded an NIAID contract to develop a rapid HIV diagnostic device

Advanced Liquid Logic announced today that it has received a large, four-year contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for the development of a rapid, point-of-care, diagnostic device for the detection of HIV in low resource settings.

3 Oct 2009

International Society for Hip Arthroscopy to focus on new procedures for hip surgery at its inaugural meeting

Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.

3 Oct 2009

61 institutions awarded grants for cancer research from American Cancer Society

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 new national research and training grants totaling $45,097,000 to 61 institutions nationwide in the second of two grants cycles for 2009. The grants go into effect beginning January 1, 2010.

3 Oct 2009

NCI selects Integral Molecular to map epitopes for monoclonal antibodies

Integral Molecular, Inc. has been selected by the National Cancer Institute (NCI) to map epitopes for monoclonal antibodies directed against cancer biomarkers. Protein targets of interest to the Clinical Cancer Proteomics community will be analyzed using Shotgun Mutagenesis Mapping technology to identify amino acids that are essential for antibody binding, allowing the discovery and characterization of cancer-specific biomarkers.

1 Oct 2009

New molecular imaging technique raises hope for common malignant female tumor

A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. This research was presented in a study published in the October issue of The Journal of Nuclear Medicine.

1 Oct 2009

Screening and diagnostic tests contribute to health care value across spectrum of care

Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.

1 Oct 2009

Fast track assessment facilities can contribute to timely evaluation of lung malignancies

Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to diagnose lung cancer in a "fast-tracked" outpatient setting. This novel approach to the diagnosis of lung cancer demonstrated a high level of sensitivity (97%) and accuracy (82%).

1 Oct 2009

TMS closes final tranche of Series E Preferred Financing to a total of $6 million

TechniScan Medical Systems (TMS) Inc., a Salt Lake City-based developer of ultrasound technology for breast imaging, announced the close of the final tranche of their Series E Preferred Financing of $1.1 million, bringing the total raised in the Series E financing to just over $6 million.

1 Oct 2009

Invivo Corporation introduces advanced clinical prostate visualization system

The introduction of Invivo Corporation's DynaCAD for Prostate advanced clinical visualization and MR interventional system brings new hope to patients and new confidence to their care providers, a positive development this Prostate Cancer Awareness Month.

1 Oct 2009

Daniel Callahan reveals how medical technology costs can destroy one's health care system

Your elderly father is ill. Would you be prepared to tell him that he will not be getting the necessary diagnostic tests because he is over the age of 65? TAMING THE BELOVED BEAST: How Medical Technology Costs are Destroying Our Health Care System (Cloth $29.95, 978-0-691-14236-4, September 30, 2009) is a provocative new take on the toughest issue President Obama has yet faced in office.

1 Oct 2009

Phase 1 clinical trial to test safety and activity of human MAB launched in India

MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.

1 Oct 2009

North Shore-LIJ Health System to implement the largest EHR program in the New York metropolitan area

The North Shore-LIJ Health System announced today it is subsidizing up to 85 percent of the cost of implementing and operating an Electronic Health Records (EHR) system in the offices of its more than 7,000 affiliated physicians in New York City and Long Island -- part of a $400 million investment to strengthen the quality of care throughout the region by automating inpatient and outpatient records in all medical settings, including 13 hospitals.

1 Oct 2009

Researchers develop integrated treatment program for PTSD affected veterans

The wars in Iraq and Afghanistan have resulted in a growing number of soldiers evacuated to the United States for comprehensive care for physical and psychological trauma. Given the number of physical injuries often experienced by soldiers, it is not surprising that chronic pain is a frequent problem among returning soldiers from Operation Iraqi Freedom and Operation Enduring Freedom (OIF/OEF). Common sources of pain are in the head (traumatic-brain injury or post-concussion syndrome), legs (fractures, amputations, burns) and shoulders.

1 Oct 2009

OSI Systems to deliver DexaCare bone densitometers for international customer

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that it has received a contract for approximately $1.3 million from an undisclosed international customer to deliver its DTX-200 DexaCare® bone densitometers.

1 Oct 2009

NCD recommends health care reform for disabled people

The National Council on Disability (NCD) today released a report entitled The Current State of Health Care for People with Disabilities, calling for immediate health care reform for people with disabilities.

1 Oct 2009

UCF research team develops miniature diagnostic tool kit for dementia

With the risk of developing dementia growing at an alarming pace, a University of Central Florida research team is working with the Boston University School of Medicine to develop a miniature diagnostic toolkit in the hopes of stimulating earlier detection and treatment.

1 Oct 2009

Cost-effective screening test for coronary artery disease

A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death.

1 Oct 2009

Immunocellular Therapeutics' pilot study can help in early cancer detection

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.

30 Sep 2009

Diagnostic News and Research

IMRISNV and IMRIScardio to be installed in BWH's AMIGO suite

Texas Health Presbyterian Hospital opens Hamon Tower for treating critically ill patients

Advanced Liquid Logic awarded an NIAID contract to develop a rapid HIV diagnostic device

International Society for Hip Arthroscopy to focus on new procedures for hip surgery at its inaugural meeting

61 institutions awarded grants for cancer research from American Cancer Society

NCI selects Integral Molecular to map epitopes for monoclonal antibodies

New molecular imaging technique raises hope for common malignant female tumor

Screening and diagnostic tests contribute to health care value across spectrum of care

Fast track assessment facilities can contribute to timely evaluation of lung malignancies

TMS closes final tranche of Series E Preferred Financing to a total of $6 million

Invivo Corporation introduces advanced clinical prostate visualization system

Daniel Callahan reveals how medical technology costs can destroy one's health care system

Phase 1 clinical trial to test safety and activity of human MAB launched in India

North Shore-LIJ Health System to implement the largest EHR program in the New York metropolitan area

Researchers develop integrated treatment program for PTSD affected veterans

OSI Systems to deliver DexaCare bone densitometers for international customer

NCD recommends health care reform for disabled people

UCF research team develops miniature diagnostic tool kit for dementia

Cost-effective screening test for coronary artery disease

Immunocellular Therapeutics' pilot study can help in early cancer detection

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News